Jul 9, 2026 08:06AM
Jul 9, 2026 08:05AM
Jun 18, 2026 08:05AM
Jun 18, 2026 08:05AM
Jun 9, 2026 08:05AM
Jun 9, 2026 08:05AM
Jun 2, 2026 08:06AM SCIENTURE receives patent for naloxone nasal spray through 2041
Jun 2, 2026 08:05AM
May 18, 2026 08:39AM
May 18, 2026 08:38AM
May 7, 2026 08:06AM
May 7, 2026 08:05AM
May 7, 2026 08:05AM
May 7, 2026 08:05AM Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline
May 6, 2026 08:05AM
May 6, 2026 08:05AM
Apr 15, 2026 08:05AM
Apr 15, 2026 08:05AM
Apr 6, 2026 08:06AM
Apr 6, 2026 08:05AM
Mar 30, 2026 08:08AM SCIENTURE reports 216% revenue growth in 2025 driven by Arbli launch
Mar 30, 2026 08:07AM
Mar 11, 2026 08:06AM
Mar 11, 2026 08:05AM
Feb 3, 2026 08:06AM
Feb 3, 2026 08:05AM
Jan 14, 2026 08:06AM
Jan 14, 2026 08:05AM SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment
Dec 22, 2025 08:05AM
Dec 22, 2025 08:05AM
Dec 10, 2025 08:05AM
Dec 10, 2025 08:05AM
Nov 13, 2025 08:05AM
Nov 4, 2025 08:05AM
Nov 4, 2025 08:05AM SCIENTURE Announces Addition of Arbli™ (Losartan Potassium) to Formularies of Major National Health Plans
Oct 23, 2025 08:05AM
Oct 23, 2025 08:05AM
Oct 1, 2025 09:00AM
Sep 16, 2025 08:05AM
Sep 16, 2025 08:05AM
Jul 16, 2025 08:15AM
Jul 16, 2025 08:15AM Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
Jun 17, 2025 08:05AM
Jun 17, 2025 08:05AM
May 22, 2025 08:20AM
May 22, 2025 08:05AM
Apr 3, 2025 08:26AM
Apr 3, 2025 08:26AM
Mar 25, 2025 08:05AM Scienture Holdings (SCNX) Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health
Mar 25, 2025 08:05AM

325,901 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All